ArticleOncoTargets and therapy2020

Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance.

Sha Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.